Henry Schein Inc. (HSIC) Shares Down 1.4%
Henry Schein Inc. (NASDAQ:HSIC) was down 1.4% during mid-day trading on Tuesday . The stock traded as low as $160.18 and last traded at $160.23, with a volume of 242,580 shares. The stock had previously closed at $162.48.
A number of research analysts have weighed in on HSIC shares. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Tuesday, April 26th. Vetr raised shares of Henry Schein from a “hold” rating to a “buy” rating and set a $176.75 price target on the stock in a research report on Monday, May 2nd. Barrington Research reaffirmed an “outperform” rating and set a $188.00 price target (up from $182.00) on shares of Henry Schein in a research report on Wednesday, May 4th. Leerink Swann reaffirmed a “hold” rating on shares of Henry Schein in a research report on Thursday, May 5th. Finally, Credit Suisse Group AG reaffirmed a “hold” rating on shares of Henry Schein in a research report on Saturday, June 4th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $155.37.
The stock’s 50 day moving average price is $173.80 and its 200-day moving average price is $171.03. The stock has a market cap of $13.13 billion and a P/E ratio of 27.19.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, beating analysts’ consensus estimates of $1.63 by $0.01. The business earned $2.87 billion during the quarter, compared to analyst estimates of $2.85 billion. Henry Schein’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.46 EPS. Equities research analysts forecast that Henry Schein Inc. will post $6.57 EPS for the current fiscal year.
In other news, EVP Gerald A. Benjamin sold 9,991 shares of the company’s stock in a transaction dated Thursday, June 2nd. The stock was sold at an average price of $175.08, for a total value of $1,749,224.28. Following the transaction, the executive vice president now owns 54,885 shares in the company, valued at approximately $9,609,265.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
A number of institutional investors have recently added to or reduced their stakes in HSIC. Victory Capital Management Inc. increased its position in Henry Schein by 18.8% in the fourth quarter. Victory Capital Management Inc. now owns 8,124 shares of the company’s stock worth $1,285,000 after buying an additional 1,284 shares in the last quarter. Utah Retirement Systems increased its position in Henry Schein by 0.7% in the fourth quarter. Utah Retirement Systems now owns 15,125 shares of the company’s stock worth $2,393,000 after buying an additional 100 shares in the last quarter. Marshall Wace LLP purchased a new position in Henry Schein during the fourth quarter worth approximately $3,743,000. American International Group Inc. increased its position in Henry Schein by 2.3% in the fourth quarter. American International Group Inc. now owns 34,438 shares of the company’s stock worth $5,447,000 after buying an additional 762 shares in the last quarter. Finally, KBC Group NV increased its position in Henry Schein by 594.3% in the fourth quarter. KBC Group NV now owns 35,692 shares of the company’s stock worth $5,646,000 after buying an additional 30,551 shares in the last quarter.
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.